Mucopolysaccharidosis Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Mucopolysaccharidosis Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mucopolysaccharidosis Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mucopolysaccharidosis Therapeutics Overall Market Size
2.1 Global Mucopolysaccharidosis Therapeutics Market Size: 2021 VS 2028
2.2 Global Mucopolysaccharidosis Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mucopolysaccharidosis Therapeutics Players in Global Market
3.2 Top Global Mucopolysaccharidosis Therapeutics Companies Ranked by Revenue
3.3 Global Mucopolysaccharidosis Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Mucopolysaccharidosis Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Mucopolysaccharidosis Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mucopolysaccharidosis Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Mucopolysaccharidosis Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Mucopolysaccharidosis Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Mucopolysaccharidosis Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Intravenous
4.1.3 Intracerebroventricular (ICV)
4.2 By Type - Global Mucopolysaccharidosis Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Mucopolysaccharidosis Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Mucopolysaccharidosis Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Mucopolysaccharidosis Therapeutics Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Mucopolysaccharidosis Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Mucopolysaccharidosis Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Mucopolysaccharidosis Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Mucopolysaccharidosis Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Mucopolysaccharidosis Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Mucopolysaccharidosis Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Mucopolysaccharidosis Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Mucopolysaccharidosis Therapeutics Revenue, 2017-2028
6.3.2 US Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.3.3 Canada Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.3.4 Mexico Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Mucopolysaccharidosis Therapeutics Revenue, 2017-2028
6.4.2 Germany Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.4.3 France Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.4.4 U.K. Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.4.5 Italy Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.4.6 Russia Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.4.8 Benelux Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Mucopolysaccharidosis Therapeutics Revenue, 2017-2028
6.5.2 China Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.5.3 Japan Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.5.4 South Korea Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.5.6 India Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Mucopolysaccharidosis Therapeutics Revenue, 2017-2028
6.6.2 Brazil Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.6.3 Argentina Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Mucopolysaccharidosis Therapeutics Revenue, 2017-2028
6.7.2 Turkey Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.7.3 Israel Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
6.7.5 UAE Mucopolysaccharidosis Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Shire (Takeda Pharmaceutical Company Limited)
7.1.1 Shire (Takeda Pharmaceutical Company Limited) Corporate Summary
7.1.2 Shire (Takeda Pharmaceutical Company Limited) Business Overview
7.1.3 Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Therapeutics Major Product Offerings
7.1.4 Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Shire (Takeda Pharmaceutical Company Limited) Key News
7.2 Denali Therapeutics
7.2.1 Denali Therapeutics Corporate Summary
7.2.2 Denali Therapeutics Business Overview
7.2.3 Denali Therapeutics Mucopolysaccharidosis Therapeutics Major Product Offerings
7.2.4 Denali Therapeutics Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Denali Therapeutics Key News
7.3 ArmaGen
7.3.1 ArmaGen Corporate Summary
7.3.2 ArmaGen Business Overview
7.3.3 ArmaGen Mucopolysaccharidosis Therapeutics Major Product Offerings
7.3.4 ArmaGen Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.3.5 ArmaGen Key News
7.4 REGENXBIO Inc.
7.4.1 REGENXBIO Inc. Corporate Summary
7.4.2 REGENXBIO Inc. Business Overview
7.4.3 REGENXBIO Inc. Mucopolysaccharidosis Therapeutics Major Product Offerings
7.4.4 REGENXBIO Inc. Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.4.5 REGENXBIO Inc. Key News
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Corporate Summary
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics Mucopolysaccharidosis Therapeutics Major Product Offerings
7.5.4 Sangamo Therapeutics Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Sangamo Therapeutics Key News
7.6 BioMarin
7.6.1 BioMarin Corporate Summary
7.6.2 BioMarin Business Overview
7.6.3 BioMarin Mucopolysaccharidosis Therapeutics Major Product Offerings
7.6.4 BioMarin Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.6.5 BioMarin Key News
7.7 Lysogene
7.7.1 Lysogene Corporate Summary
7.7.2 Lysogene Business Overview
7.7.3 Lysogene Mucopolysaccharidosis Therapeutics Major Product Offerings
7.7.4 Lysogene Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Lysogene Key News
7.8 Abeona Therapeutics Inc.
7.8.1 Abeona Therapeutics Inc. Corporate Summary
7.8.2 Abeona Therapeutics Inc. Business Overview
7.8.3 Abeona Therapeutics Inc. Mucopolysaccharidosis Therapeutics Major Product Offerings
7.8.4 Abeona Therapeutics Inc. Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Abeona Therapeutics Inc. Key News
7.9 Ultragenyx Pharmaceutical
7.9.1 Ultragenyx Pharmaceutical Corporate Summary
7.9.2 Ultragenyx Pharmaceutical Business Overview
7.9.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis Therapeutics Major Product Offerings
7.9.4 Ultragenyx Pharmaceutical Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Ultragenyx Pharmaceutical Key News
7.10 Genzyme Corporation
7.10.1 Genzyme Corporation Corporate Summary
7.10.2 Genzyme Corporation Business Overview
7.10.3 Genzyme Corporation Mucopolysaccharidosis Therapeutics Major Product Offerings
7.10.4 Genzyme Corporation Mucopolysaccharidosis Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Genzyme Corporation Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Mucopolysaccharidosis Therapeutics Market Opportunities & Trends in Global Market
Table 2. Mucopolysaccharidosis Therapeutics Market Drivers in Global Market
Table 3. Mucopolysaccharidosis Therapeutics Market Restraints in Global Market
Table 4. Key Players of Mucopolysaccharidosis Therapeutics in Global Market
Table 5. Top Mucopolysaccharidosis Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Mucopolysaccharidosis Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Mucopolysaccharidosis Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Mucopolysaccharidosis Therapeutics Product Type
Table 9. List of Global Tier 1 Mucopolysaccharidosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mucopolysaccharidosis Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Mucopolysaccharidosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Mucopolysaccharidosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Mucopolysaccharidosis Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Mucopolysaccharidosis Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Shire (Takeda Pharmaceutical Company Limited) Corporate Summary
Table 31. Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Therapeutics Product Offerings
Table 32. Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Denali Therapeutics Corporate Summary
Table 34. Denali Therapeutics Mucopolysaccharidosis Therapeutics Product Offerings
Table 35. Denali Therapeutics Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. ArmaGen Corporate Summary
Table 37. ArmaGen Mucopolysaccharidosis Therapeutics Product Offerings
Table 38. ArmaGen Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. REGENXBIO Inc. Corporate Summary
Table 40. REGENXBIO Inc. Mucopolysaccharidosis Therapeutics Product Offerings
Table 41. REGENXBIO Inc. Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sangamo Therapeutics Corporate Summary
Table 43. Sangamo Therapeutics Mucopolysaccharidosis Therapeutics Product Offerings
Table 44. Sangamo Therapeutics Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. BioMarin Corporate Summary
Table 46. BioMarin Mucopolysaccharidosis Therapeutics Product Offerings
Table 47. BioMarin Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Lysogene Corporate Summary
Table 49. Lysogene Mucopolysaccharidosis Therapeutics Product Offerings
Table 50. Lysogene Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Abeona Therapeutics Inc. Corporate Summary
Table 52. Abeona Therapeutics Inc. Mucopolysaccharidosis Therapeutics Product Offerings
Table 53. Abeona Therapeutics Inc. Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Ultragenyx Pharmaceutical Corporate Summary
Table 55. Ultragenyx Pharmaceutical Mucopolysaccharidosis Therapeutics Product Offerings
Table 56. Ultragenyx Pharmaceutical Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Genzyme Corporation Corporate Summary
Table 58. Genzyme Corporation Mucopolysaccharidosis Therapeutics Product Offerings
Table 59. Genzyme Corporation Mucopolysaccharidosis Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Mucopolysaccharidosis Therapeutics Segment by Type in 2021
Figure 2. Mucopolysaccharidosis Therapeutics Segment by Application in 2021
Figure 3. Global Mucopolysaccharidosis Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Mucopolysaccharidosis Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Mucopolysaccharidosis Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mucopolysaccharidosis Therapeutics Revenue in 2021
Figure 8. By Type - Global Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Mucopolysaccharidosis Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Mucopolysaccharidosis Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Shire (Takeda Pharmaceutical Company Limited) Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Denali Therapeutics Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ArmaGen Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. REGENXBIO Inc. Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sangamo Therapeutics Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioMarin Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lysogene Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Abeona Therapeutics Inc. Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ultragenyx Pharmaceutical Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genzyme Corporation Mucopolysaccharidosis Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
